Core Viewpoint - Nu Skin Enterprises, Inc. (NUS) is expected to report declines in both revenue and earnings for the fourth quarter of 2025, with revenue estimates at $382.7 million, reflecting a 14.1% decrease year-over-year [1]. Revenue Expectations - The Zacks Consensus Estimate for quarterly revenues is set at $382.7 million, indicating a 14.1% decline from the previous year's quarter [1]. - Management has guided fourth-quarter revenues between $365 million and $400 million, suggesting a year-over-year decline of 10-18% [4]. - Excluding the contribution from the divested Mavely business, revenues are projected to fall by 12-3% [4]. Earnings Projections - The consensus estimate for quarterly earnings remains unchanged at 30 cents per share, which represents a 21.1% decline from the same quarter last year [2]. - Nu Skin anticipates fourth-quarter earnings per share to be between 25 and 35 cents, down from adjusted earnings of 38 cents reported in the previous year [6]. Market Conditions - The company is facing a challenging macroeconomic environment affecting discretionary spending in beauty and wellness [3]. - There has been a decline in customers, paid affiliates, and sales leaders, indicating ongoing pressures in several markets [3]. - Increased competition in the social commerce beauty space, particularly in North America, is also impacting performance [4]. Geographic Performance - Latin America has shown strong performance, with revenues increasing by 53% year-over-year in the third quarter [5]. - Sequential growth was reported in Europe & Africa, Southeast Asia Pacific, South Korea, and Hong Kong & Taiwan, with improving trends noted in Mainland China [5]. Strategic Initiatives - The limited sales leader preview of Prysm iO and the start of pre-market activities in India are expected to influence fourth-quarter performance positively [5]. - Despite the anticipated decline in sales, Nu Skin has achieved five consecutive quarters of adjusted gross margin expansion, supported by product mix improvements and cost discipline [6].
Nu Skin Gears Up to Report Q4 Earnings: What's in the Offing?